GeneOS

3 articles with GeneOS

• Geneos Therapeutics Announces Clinical Updates on Personalized Cancer Vaccine Program

  6/3/2021

  Highlighting its Phase Ib/IIa trial in advanced hepatocellular cancer and a case study for treatment of anaplastic astrocytoma at the American Society of Clinical Oncology (ASCO) Data from first 10 patients in the HCC trial demonstrates clinical responses

• Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs

  3/3/2021

  Geneos expands its lead program for treating patients with advanced hepatocellular carcinoma

• Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies

  2/21/2019

  Geneos has Licensed Immunotherapy Platform from Inovio Pharmaceuticals for Developing Personalized Cancer Treatments